Camp4 Therapeutics (CAMP) Research & Development (2023 - 2026)

Camp4 Therapeutics has reported Research & Development for 4 years, with the latest figure at $10.2 million in Q1 2026.

• Quarterly Research & Development changed 0.14% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $214000.0 (down 99.45% YoY) and the FY2025 annual result came in at $200000.0, down 99.48% from the prior year.
• Research & Development improved to $10.2 million in Q1 2026 per CAMP's latest filing, from -$29.6 million in the prior quarter.
• Over five years, Research & Development peaked at $10.7 million in Q4 2023 and troughed at -$29.6 million in Q4 2025.
• A 4-year average of $6.3 million and a median of $9.8 million in 2023 frame the typical range for Research & Development.
• The widest YoY moves for Research & Development: up 10.16% in 2025, down 396.57% in 2025.
• Over 4 years, Research & Development stood at $10.7 million in 2023, then fell by 6.24% to $10.0 million in 2024, then slumped by 396.57% to -$29.6 million in 2025, then jumped by 134.27% to $10.2 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $10.2 million, -$29.6 million, and $9.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.